Carbonyl Reductase 1/CBR1 Antibody

Carbonyl Reductase 1 / CBR1 is an NADPH-dependent reductase with broad substrate specificity. It catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. It also catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Carbonyl Reductase 1 / CBR1 can convert prostaglandin E2 to prostaglandin F2-alpha [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/P16152].
CBR1
carbonyl reductase 1
Carbonyl reductase [NADPH] 1
:  15-hydroxyprostaglandin dehydrogenase 15-hydroxyprostaglandin dehydrogenase [NADP(+)] carbonyl reductase (NADPH) 1 CBR hCBR1 NADPH-dependent carbonyl reductase 1 prostaglandin 9-ketoreductase prostaglandin-E(2) 9-reductase SDR21C1 short chain dehydrogenase/reductase family 21C member 1 short chain dehydrogenase/reductase family 21C, member 1 More... Less...
Product
Specifications
Ordering Information
Human
WB, IP
Between 227 and 277
$339
$229
$99
Human
WB, IP
Between 227 and 277
$339
$229
$99
Human
WB, IP
Includes: 1 each of A304-772A and A304-773A
$472
Includes: 1 each of A304-772A and A304-773A